The lab's research is focused on the design and implementation of processes and equipment to manufacture nanoscale materials and devices. The focus is on three areas: 1) develop new assembly methods to better integrate nanomaterials into micro/macroscale devices; 2) increase manufacturability of nanoscale systems through improved device design; and 3) improve quality and throughput of nanoscale device manufacturing through the design and fabrication of novel nanomanufacturing equipment and processes.
The Ruoff group is located in the department of Mechanical Engineering at the University of Texas. Major interests are: Synthesis and properties of nanostructures including CNTs and graphene; Energy and the Environment; Preparation and properties of composites; Nanomanipulation and nanorobotics; Instrument development and technology transition; New tools and methods for the biomedical sciences.
Students who have a strong background in any of the physical sciences or engineering disciplines are encouraged to apply to the Graduate Program in Materials Science and Engineering. MS&E students that select the Nanomaterials Thrust will take a sequence of courses from basic to advanced designed to train them in the fundamentals of materials science as well as critical skills in processing, characterization and applications of nanomaterials.
SWAN is one of the three centers created in 2006 by the Semiconductor Research Corporation Nanoelectronics Research Initiative ( SRC-NRI) to find a replacement to conventional metal oxide semiconductor field effect transistors. SRC-NRI is a consortium of TI, Freescale, AMD, MICRON, Intel and IBM.
The research group of Walter Hu focuses on integrating nanoscale elements of electronics, chemistry, and biology. Such nano-bio-engineering fusion may provide rare opportunities to explore new science and applications.
The Department of NanoMedicine and Biomedical Engineering is focused on inter-disciplinary research combining NanoMedicine, Biomedical Engineering and computational sciences to develop novel therapeutic and diagnostic platforms for combating diseases including cancer, cardiovascular diseases and infectious diseases.